Similar articles for PMID: 14565606

Year	Number of Results
1996	1
1998	2
1999	7
2000	16
2001	22
2002	21
2003	29
2004	12
2005	9
2006	9
2007	8
2008	10
2009	15
2010	12
2011	12
2012	6
2013	7
2014	4
2015	3
2016	7
2017	7
2018	2
2019	5
2020	11
2021	10
2022	4
2023	3
2024	0

1

Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS-Drug Access Initiative in Abidjan, Côte d'Ivoire.

Adjé-Touré C, Celestin B, Hanson D, Roels TH, Hertogs K, Larder B, Diomande F, Peeters M, Eholié S, Lackritz E, Chorba T, Nkengasong JN. Adjé-Touré C, et al. AIDS. 2003 Jul;17 Suppl 3:S23-9. doi: 10.1097/00002030-200317003-00004. AIDS. 2003. PMID: 14565606

2

High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.

Adjé C, Cheingsong R, Roels TH, Maurice C, Djomand G, Verbiest W, Hertogs K, Larder B, Monga B, Peeters M, Eholie S, Bissagene E, Coulibaly M, Respess R, Wiktor SZ, Chorba T, Nkengasong JN; UNAIDS HIV Drug Access Initiative, Abidjan, Côte d'Ivoire. Adjé C, et al. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):501-6. doi: 10.1097/00126334-200104150-00018. J Acquir Immune Defic Syndr. 2001. PMID: 11391173

3

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.

Adjé-Touré CA, Cheingsong R, Garcìa-Lerma JG, Eholié S, Borget MY, Bouchez JM, Otten RA, Maurice C, Sassan-Morokro M, Ekpini RE, Nolan M, Chorba T, Heneine W, Nkengasong JN. Adjé-Touré CA, et al. AIDS. 2003 Jul;17 Suppl 3:S49-54. AIDS. 2003. PMID: 14565609

4

Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire.

Bilé EC, Adjé-Touré C, Borget MY, Kalou M, Diomande F, Chorba T, Nkengasong JN. Bilé EC, et al. J Clin Virol. 2005 Jan;32(1):60-6. doi: 10.1016/j.jcv.2004.07.008. J Clin Virol. 2005. PMID: 15572008

5

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E. Vergne L, et al. AIDS. 2003 Jul;17 Suppl 3:S31-8. doi: 10.1097/00002030-200317003-00005. AIDS. 2003. PMID: 14565607

6

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.

Weidle PJ, Downing R, Sozi C, Mwebaze R, Rukundo G, Malamba S, Respess R, Hertogs K, Larder B, Ochola D, Mermin J, Samb B, Lackritz E. Weidle PJ, et al. AIDS. 2003 Jul;17 Suppl 3:S39-48. doi: 10.1097/00002030-200317003-00006. AIDS. 2003. PMID: 14565608

7

Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'Ivoire.

Chaix ML, Rouet F, Kouakoussui KA, Laguide R, Fassinou P, Montcho C, Blanche S, Rouzioux C, Msellati P. Chaix ML, et al. Pediatr Infect Dis J. 2005 Dec;24(12):1072-6. doi: 10.1097/01.inf.0000190413.88671.92. Pediatr Infect Dis J. 2005. PMID: 16371868

8

HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.

Hanson DL, Adjé-Touré C, Talla-Nzussouo N, Eby P, Borget MY, Kouadio LY, Celestin BE, Tossou O, Eholie S, Kadio A, Chorba T, Nkengasong JN. Hanson DL, et al. AIDS Res Hum Retroviruses. 2009 May;25(5):489-95. doi: 10.1089/aid.2008.0273. AIDS Res Hum Retroviruses. 2009. PMID: 19388820

9

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.

Djomand G, Roels T, Ellerbrock T, Hanson D, Diomande F, Monga B, Maurice C, Nkengasong J, Konan-Koko R, Kadio A, Wiktor S, Lackritz E, Saba J, Chorba T. Djomand G, et al. AIDS. 2003 Jul;17 Suppl 3:S5-15. doi: 10.1097/00002030-200317003-00002. AIDS. 2003. PMID: 14565604

10

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.

Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouédraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouédraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timité-Konan M, Leroy V; MONOD Study Group. Dahourou DL, et al. BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4. BMC Med. 2017. PMID: 28434406 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

240 results

Results by year